Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/20981484

Download in:

View as

General Info

PMID
20981484